Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
99.94
+3.23 (3.34%)
At close: May 12, 2026, 4:00 PM EDT
100.02
+0.08 (0.08%)
After-hours: May 12, 2026, 7:57 PM EDT

Guardant Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
13,25213,3433,7883,2902,79110,179
Market Cap Growth
123.74%252.25%15.13%17.87%-72.58%-21.19%
Enterprise Value
13,85413,8244,2553,4473,12710,607
Last Close Price
99.94102.1430.5527.0527.20100.02
PE Ratio
--30.77-8.58-6.32-4.24-25.00
PS Ratio
12.2713.595.135.836.2127.24
PB Ratio
--134.36-27.1320.7346.3815.78
P/TBV Ratio
-70.21-128.95-26.8519.0946.1815.71
P/FCF Ratio
--57.25-13.78-9.52-7.21-35.83
P/OCF Ratio
--72.22-15.79-10.12-9.02-48.70
EV/Sales Ratio
12.8314.085.766.116.9628.39
EV/EBITDA Ratio
--34.78-10.61-6.61-6.15-27.29
EV/EBIT Ratio
--31.62-9.59-6.10-5.74-25.81
EV/FCF Ratio
--59.31-15.48-9.98-8.08-37.34
Debt / Equity Ratio
-9.26-16.94-9.368.3622.392.11
Debt / EBITDA Ratio
-4.10-4.23-3.26-2.54-2.65-3.50
Debt / FCF Ratio
-7.07-7.22-4.75-3.84-3.48-4.79
Net Debt / Equity Ratio
-3.17-4.84-3.340.995.590.66
Net Debt / EBITDA Ratio
-1.40-1.21-1.16-0.30-0.66-1.10
Net Debt / FCF Ratio
-2.42-2.06-1.70-0.45-0.87-1.51
Asset Turnover
0.550.560.450.330.240.17
Inventory Turnover
4.474.454.364.003.804.60
Quick Ratio
4.254.424.216.115.745.29
Current Ratio
4.684.844.686.546.175.72
Return on Equity (ROE)
309.00%348.42%-4584.47%-438.12%-185.65%-38.47%
Return on Assets (ROA)
-22.72%-24.92%-27.19%-33.32%-28.59%-18.38%
Return on Invested Capital (ROIC)
-79.12%-85.85%-100.50%-132.72%-68.62%-51.90%
Return on Capital Employed (ROCE)
-26.85%-29.43%-31.23%-37.68%-31.77%-19.50%
Earnings Yield
-3.27%-3.25%-11.65%-15.82%-23.57%-4.00%
FCF Yield
-1.79%-1.75%-7.26%-10.50%-13.86%-2.79%
Buyback Yield / Dilution
-3.20%-2.14%-9.61%-9.60%-0.85%-3.91%
Total Shareholder Return
-3.20%-2.14%-9.61%-9.60%-0.85%-3.91%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q